tiprankstipranks
Trending News
More News >
Structure Therapeutics, Inc. Sponsored ADR (GPCR)
NASDAQ:GPCR
US Market
Advertisement

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Ownership - Who Owns Structure Therapeutics, Inc. Sponsored ADR?

Compare
1,036 Followers

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Ownership Overview

11.95%30.77%46.05%0.91%10.32%
11.95% Insiders
46.05% Other Institutional Investors
0.91% ETFs
10.32% Public Companies and Individual Investors
The ownership structure of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is a mix of institutional, retail, and individual investors. Approximately 77.73% of the company’s stock is owned by Institutional Investors, 11.95% is owned by Insiders, and 10.32% is owned by Public Companies and Individual Investors.
The ownership structure of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is a mix of institutional, retail, and individual investors. Approximately 76.82% of the company’s stock is owned by Institutional Investors, 11.95% is owned by Insiders, and 0.91% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2025
xxxxxxxxxxxxx
$60809
Jun 30, 2025
xxxxxxxxxxxxx
$3659635
Jun 30, 2025
xxxxxxxxxxxxx
$13953706
Jun 30, 2025
xxxxxxxxxxxxx
$52031827

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,414,573Institution7.66%88,821,209
3,800,961Institution6.60%76,475,335
2,874,462Insider4.99%57,834,175
2,749,416Insider4.77%55,318,250
2,508,767Institution4.36%50,476,392
1,517,418Institution2.63%30,530,450
1,204,864Institution2.09%24,241,864
1,022,281Institution1.77%20,568,294
793,327Institution1.38%15,961,739
791,500Institution1.37%15,924,980

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,414,573Institution7.66%88,821,209
3,800,961Institution6.60%76,475,335
1,204,864Institution2.09%24,241,864
1,022,281Institution1.77%20,568,294
793,327Institution1.38%15,961,739
791,500Institution1.37%15,924,980
739,695Institution1.28%14,882,663
593,086Institution1.03%11,932,890
582,447Institution1.01%11,718,834
450,000Institution0.78%9,054,000

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
213,883Institution0.37%4,303,326
61,732Institution0.11%1,143,894
43,885Institution0.08%910,175
37,765Institution0.07%759,832
34,677Institution0.06%664,411
27,557Institution0.05%554,447
16,671Institution0.03%345,757
15,000Institution0.03%585,063
13,157Institution0.02%243,799
6,859Institution0.01%127,097

FAQ

Who Owns Structure Therapeutics, Inc. Sponsored ADR (GPCR)?
According to the latest TipRanks data, approximately 46.05% of the company's stock is held by institutional investors, 11.95% is held by insiders, and 10.32% is held by retail investors.
    What percentage of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 46.05% of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by institutional investors.
      What percentage of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by retail investors?
      According to the latest TipRanks data, approximately 10.32% of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by retail investors.
        Who owns the most shares of Structure Therapeutics, Inc. Sponsored ADR (GPCR)?
        VANGUARD SPECIALIZED FUNDS owns the most shares of Structure Therapeutics, Inc. Sponsored ADR (GPCR).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis